Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) was down 3.8% during trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares changed hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The firm has a market capitalization of C$52.28 million and a PE ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The company’s fifty day moving average price is C$0.26 and its two-hundred day moving average price is C$0.26.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- Salesforce Turns the Corner as AI Fears Start to Fade
- Could Falling Yields Make REIT Stocks Worth a Second Look?
- CrowdStrike’s “Mythos Moment” Tests the Bigger AI Security Trade
- 3 Stocks Facing New Pressure From Section 338 Tariffs on Canadian Goods
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
